ACET: Adicet Growth-Adjusted Market Cap to Net Income
Adicet Bio relies on external contractors for testing and vector creation. The company's price-to-growth ratio visualizes the dynamics of this process, where 0.00 captures the current value of the indicator. Revenues are based on the supply of allogeneic T-cells to medical centers, while pipeline risks are minimized through partnerships with global pharmaceutical behemoths.
Metric breakdowns and analytics for Adicet Bio (ACET)
- share price and consensus valuation forecast:
- market capitalization information:
- company book value details:
- issuer credit burden and liquidity indicators:
- business earnings and investment ratios data:
ACET - Net Profit|Company Profit Forecast Adicet Bio|ACET - P/E Multiple|Projected Price to Earnings adicetbio.com|ACET - PEG Multiple|Company Value to EBITDA Adicet|ACET - Operating profit before deduction of amortization|Earnings per share for the last four quarters Adicet Bio|ACET - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months adicetbio.com|ACET - Earnings growth in current year|Net earnings per share growth forecast for next year Adicet Bio
General company analysis:ACET - Adicet Bio Inc.
Adicet Bio focuses on developing innovative gamma-delta T-cell therapies to bypass traditional market competition. The dynamics of the company's price-to-growth ratio reflect the investment efficiency of these developments. This metric compares the P/E ratio with expected earnings growth, revealing the asset's undervaluation. A value below one signals high capitalization potential. This indicator helps determine the business's prospects amidst intensive clinical races.
Competing companies
ARGX (argenx N.V.) - Growth-Adjusted Payback Ratio|PEG Multiple BNTX (BioNTech Group)|Growth-Adjusted Market Cap to Net Income Abivax (ABVX)|ADMA - Price/Earnings to Growth Ratio|protagonist-inc.com (PTGX) - Price/Earnings to Growth Multiple|Immunovant (IMVT) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple Kiniksa Pharmaceuticals, Ltd.|Price/Earnings to Growth Multiple GRFS|PEG Multiple Adaptive Biotechnologies Inc.|Price/Earnings to Growth Ratio Celldex Therapeutics (CLDX)|auriniapharma.com - Growth-Adjusted P/E Ratio|PEG Multiple BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - Price to Earnings Adjusted for Growth Rate|Dianthus Pharma - PEG Multiple|PHVS - PEG Multiple|ABCL: PEG Multiple|Growth-Adjusted P/E Ratio TRML|PGEN (Precigen) - PEG Multiple|Pharming Group NV (PHAR) - Growth-Adjusted Market Cap to Net Income|PEG Multiple NKTR|Price/Earnings to Growth Multiple Upstream Pharma UPB|PEG Multiple ZBIO (Zenas Biopharma Inc)|immunome.com (IMNM) - Price to Earnings Adjusted for Growth Rate|GOSS: Price/Earnings to Growth Multiple|KalVista Pharma - Company Value to Earnings Growth Ratio|SEPN (Septerna Corp) - Price/Earnings to Growth Multiple|Pieris Corp - Growth-Adjusted Payback Ratio|SVRA (Savara Inc.) - PEG Multiple|Price/Earnings to Growth Ratio RIGL|PEG Multiple ANAB|Growth-Adjusted Market Cap to Net Income Astria Therapeutics Inc|Price/Earnings to Growth Ratio enGene Bio ENGN|rapt.com (RAPT) - Price to Earnings Adjusted for Growth Rate|Aerovate - PEG Multiple|ACRS - PEG Multiple|KYTX: PEG Multiple|Price/Earnings to Growth Multiple Tiziana Life Sciences Ltd.|CABA (Cabaletta Bio, Inc) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Ventyx Biosciences, Inc VTYX|Price/Earnings to Growth Multiple THTX (Theratechnologies Inc.)|Company Value to Earnings Growth Ratio AVTX|Price/Earnings to Growth Ratio Eledon Pharmaceuticals, Inc. ELDN|AGEN (Agenus, Inc.) - Market Cap to Earnings and Growth Ratio|Climb Bio, Inc. - PEG Multiple|Growth-Adjusted Payback Ratio ZURA (zurabio.com)|ATYR: PEG Multiple|Adagene Inc. (ADAG) - PEG Multiple|Price/Earnings to Growth Ratio ImageneBio|STTK: Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Equillium, Inc. (EQ)|Price/Earnings to Growth Multiple connectbiopharm.com CNTB|PEG Multiple IMUX (Immunic)|PEG Multiple Atara Biotherapeutics, Inc. ATRA|IFRX: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio XFOR (X4 Pharmaceuticals Inc.)|CELU: PEG Multiple|INMB - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio Barinthus Biotherapeutics|Price/Earnings to Growth Multiple kezarlifesciences.com (KZR)|Price/Earnings to Growth Ratio SAB Biotherapeutics, Inc. (SABS)|Price/Earnings to Growth Multiple Akari Therapeutics PLC AKTX|Enlivex Therapeutics Ltd. - Price/Earnings to Growth Multiple|PEG Multiple Q32 Bio Inc QTTB|GOVX - Price/Earnings to Growth Ratio|EDSA (edesabiotech.com) - Growth-Adjusted P/E Ratio|IBIO: PEG Multiple|Price to Earnings Adjusted for Growth Rate Carisma Therapeutics Inc. (CARM)|XTLB (XTL Biopharmaceuticals, Ltd.) - PEG Multiple|PEG Multiple Bolt Bio|PEG Multiple HCWB|aptevotherapeutics.com - Growth-Adjusted P/E Ratio|PEG Multiple AIM (AIM ImmunoTech)|Growth-Adjusted Market Cap to Net Income Aditxt Inc. (ADTX)|GRI Bio Corp - PEG Multiple|XORTX Corp (XRTX) - Price/Earnings to Growth Multiple|HIND: PEG Multiple|Price to Earnings Adjusted for Growth Rate revbiosciences.com (REVB)|Price/Earnings to Growth Multiple INDP|SCNI (Scinai Immunotherapeutics Ltd) - Company Value to Earnings Growth Ratio|Price/Earnings to Growth Multiple CALI (CalciMedica, Inc.)|AFMD (affimed.com) - Growth-Adjusted Payback Ratio|PEG Multiple ALLK (Allakos)|HOOKIPA Pharma, Inc. - Price/Earnings to Growth Ratio|IGM Bio - PEG Multiple|Growth-Adjusted Market Cap to Net Income iTeos Therapeutics Inc ITOS|Ocean Bio (OCEA) - Price/Earnings to Growth Ratio|Price to Earnings Adjusted for Growth Rate TC BioPharm Ltd (TCBP)|THRD (Third Harmonic Bio) - PEG Multiple
